β3 integrins regulate lymphocyte migration and cytokine responses in heart transplant rejection

A. Lacy-Hulbert, T. Ueno, T. Ito, M. Jurewicz, A. Izawa, R. N. Smith, C. M. Chase, K. Tanaka, P. Fiorina, P. S. Russell, H. Auchincloss, M. H. Sayegh, R. O. Hynes, R. Abdi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Integrin αvβ3 is important for cell survival, signaling and migration, particularly during angiogenesis and tumorigenesis, where it has been proposed as a therapeutic target. αvβ3 is up-regulated following transplantation and β3 polymorphisms are associated with increased acute kidney rejection, suggesting that αvβ3 may also play a role in transplant rejection. Here, using a model of allogeneic heart transplantation, we show that allograft survival is prolonged in β3 integrin-deficient (β3-/-) mice. This is associated with Th2-type immune responses and reduced T-cell infiltration into grafts and T cells from β3-/- mice show impaired adhesion and migration, consistent with a role for αvβ3 in transmigration. These studies provide evidence that targeting β3 integrins impairs recruitment of effector cells and alters cytokine production, so prolonging graft survival. We also show that low doses of blocking antibodies against leukocyte function associated antigen-1 (LFA-1)/αLβ2 and very late antigen-4 (VLA-4)/α4β1, when combined with deletion of β3, lead to long-term survival of allografts with no evidence of chronic rejection. Hence we provide strong mechanistic evidence supporting previous genetic studies, demonstrate the involvement of β3 integrins in both acute and chronic rejection and identify β3 as a new target for immunosuppressive therapy.

Original languageEnglish
Pages (from-to)1080-1090
Number of pages11
JournalAmerican Journal of Transplantation
Volume7
Issue number5
DOIs
Publication statusPublished - May 2007

Fingerprint

Graft Rejection
Integrins
Lymphocytes
Cytokines
Allografts
Integrin alpha4beta1
T-Lymphocytes
Lymphocyte Function-Associated Antigen-1
Blocking Antibodies
Homologous Transplantation
Graft Survival
Heart Transplantation
Immunosuppressive Agents
Cell Movement
Cell Survival
Carcinogenesis
Transplantation
Transplants
Kidney
Therapeutics

Keywords

  • Acute rejection
  • Chronic rejection
  • Extracellular matrix
  • Integrin
  • Migration

ASJC Scopus subject areas

  • Immunology

Cite this

β3 integrins regulate lymphocyte migration and cytokine responses in heart transplant rejection. / Lacy-Hulbert, A.; Ueno, T.; Ito, T.; Jurewicz, M.; Izawa, A.; Smith, R. N.; Chase, C. M.; Tanaka, K.; Fiorina, P.; Russell, P. S.; Auchincloss, H.; Sayegh, M. H.; Hynes, R. O.; Abdi, R.

In: American Journal of Transplantation, Vol. 7, No. 5, 05.2007, p. 1080-1090.

Research output: Contribution to journalArticle

Lacy-Hulbert, A, Ueno, T, Ito, T, Jurewicz, M, Izawa, A, Smith, RN, Chase, CM, Tanaka, K, Fiorina, P, Russell, PS, Auchincloss, H, Sayegh, MH, Hynes, RO & Abdi, R 2007, 'β3 integrins regulate lymphocyte migration and cytokine responses in heart transplant rejection', American Journal of Transplantation, vol. 7, no. 5, pp. 1080-1090. https://doi.org/10.1111/j.1600-6143.2007.01757.x
Lacy-Hulbert, A. ; Ueno, T. ; Ito, T. ; Jurewicz, M. ; Izawa, A. ; Smith, R. N. ; Chase, C. M. ; Tanaka, K. ; Fiorina, P. ; Russell, P. S. ; Auchincloss, H. ; Sayegh, M. H. ; Hynes, R. O. ; Abdi, R. / β3 integrins regulate lymphocyte migration and cytokine responses in heart transplant rejection. In: American Journal of Transplantation. 2007 ; Vol. 7, No. 5. pp. 1080-1090.
@article{b118cdc27ad543afbb20009387d0f37a,
title = "β3 integrins regulate lymphocyte migration and cytokine responses in heart transplant rejection",
abstract = "Integrin αvβ3 is important for cell survival, signaling and migration, particularly during angiogenesis and tumorigenesis, where it has been proposed as a therapeutic target. αvβ3 is up-regulated following transplantation and β3 polymorphisms are associated with increased acute kidney rejection, suggesting that αvβ3 may also play a role in transplant rejection. Here, using a model of allogeneic heart transplantation, we show that allograft survival is prolonged in β3 integrin-deficient (β3-/-) mice. This is associated with Th2-type immune responses and reduced T-cell infiltration into grafts and T cells from β3-/- mice show impaired adhesion and migration, consistent with a role for αvβ3 in transmigration. These studies provide evidence that targeting β3 integrins impairs recruitment of effector cells and alters cytokine production, so prolonging graft survival. We also show that low doses of blocking antibodies against leukocyte function associated antigen-1 (LFA-1)/αLβ2 and very late antigen-4 (VLA-4)/α4β1, when combined with deletion of β3, lead to long-term survival of allografts with no evidence of chronic rejection. Hence we provide strong mechanistic evidence supporting previous genetic studies, demonstrate the involvement of β3 integrins in both acute and chronic rejection and identify β3 as a new target for immunosuppressive therapy.",
keywords = "Acute rejection, Chronic rejection, Extracellular matrix, Integrin, Migration",
author = "A. Lacy-Hulbert and T. Ueno and T. Ito and M. Jurewicz and A. Izawa and Smith, {R. N.} and Chase, {C. M.} and K. Tanaka and P. Fiorina and Russell, {P. S.} and H. Auchincloss and Sayegh, {M. H.} and Hynes, {R. O.} and R. Abdi",
year = "2007",
month = "5",
doi = "10.1111/j.1600-6143.2007.01757.x",
language = "English",
volume = "7",
pages = "1080--1090",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - β3 integrins regulate lymphocyte migration and cytokine responses in heart transplant rejection

AU - Lacy-Hulbert, A.

AU - Ueno, T.

AU - Ito, T.

AU - Jurewicz, M.

AU - Izawa, A.

AU - Smith, R. N.

AU - Chase, C. M.

AU - Tanaka, K.

AU - Fiorina, P.

AU - Russell, P. S.

AU - Auchincloss, H.

AU - Sayegh, M. H.

AU - Hynes, R. O.

AU - Abdi, R.

PY - 2007/5

Y1 - 2007/5

N2 - Integrin αvβ3 is important for cell survival, signaling and migration, particularly during angiogenesis and tumorigenesis, where it has been proposed as a therapeutic target. αvβ3 is up-regulated following transplantation and β3 polymorphisms are associated with increased acute kidney rejection, suggesting that αvβ3 may also play a role in transplant rejection. Here, using a model of allogeneic heart transplantation, we show that allograft survival is prolonged in β3 integrin-deficient (β3-/-) mice. This is associated with Th2-type immune responses and reduced T-cell infiltration into grafts and T cells from β3-/- mice show impaired adhesion and migration, consistent with a role for αvβ3 in transmigration. These studies provide evidence that targeting β3 integrins impairs recruitment of effector cells and alters cytokine production, so prolonging graft survival. We also show that low doses of blocking antibodies against leukocyte function associated antigen-1 (LFA-1)/αLβ2 and very late antigen-4 (VLA-4)/α4β1, when combined with deletion of β3, lead to long-term survival of allografts with no evidence of chronic rejection. Hence we provide strong mechanistic evidence supporting previous genetic studies, demonstrate the involvement of β3 integrins in both acute and chronic rejection and identify β3 as a new target for immunosuppressive therapy.

AB - Integrin αvβ3 is important for cell survival, signaling and migration, particularly during angiogenesis and tumorigenesis, where it has been proposed as a therapeutic target. αvβ3 is up-regulated following transplantation and β3 polymorphisms are associated with increased acute kidney rejection, suggesting that αvβ3 may also play a role in transplant rejection. Here, using a model of allogeneic heart transplantation, we show that allograft survival is prolonged in β3 integrin-deficient (β3-/-) mice. This is associated with Th2-type immune responses and reduced T-cell infiltration into grafts and T cells from β3-/- mice show impaired adhesion and migration, consistent with a role for αvβ3 in transmigration. These studies provide evidence that targeting β3 integrins impairs recruitment of effector cells and alters cytokine production, so prolonging graft survival. We also show that low doses of blocking antibodies against leukocyte function associated antigen-1 (LFA-1)/αLβ2 and very late antigen-4 (VLA-4)/α4β1, when combined with deletion of β3, lead to long-term survival of allografts with no evidence of chronic rejection. Hence we provide strong mechanistic evidence supporting previous genetic studies, demonstrate the involvement of β3 integrins in both acute and chronic rejection and identify β3 as a new target for immunosuppressive therapy.

KW - Acute rejection

KW - Chronic rejection

KW - Extracellular matrix

KW - Integrin

KW - Migration

UR - http://www.scopus.com/inward/record.url?scp=34247525543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247525543&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2007.01757.x

DO - 10.1111/j.1600-6143.2007.01757.x

M3 - Article

C2 - 17359504

AN - SCOPUS:34247525543

VL - 7

SP - 1080

EP - 1090

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 5

ER -